Naoto Ueno

70PUBLICATIONS
267CO-AUTHORS
HaematologyTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|May 13, 2026
An Integrated Academic Oncology Ecosystem for Hawai'i and the U.S.-Affiliated Pacific Islands.

|May 01, 2026
Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma.

|Apr 15, 2026
ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.

|Mar 24, 2026
Understanding and Overcoming Antibody-Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer.

Minji Seo, Jangsoon Lee, Naoto T Ueno

|Jan 27, 2026
Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer.

Dileep Reddy Rampa, Minji Seo, Nanae Ogata

|Oct 18, 2025
Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer.

Takeo Fujii, Toshiaki Iwase, Yu Shen

Pageof 12

Frequent Collaborators

21 joint publications

Debu Tripathy

12 joint publications

Bora Lim

10 joint publications

Toshiaki Iwase

7 joint publications

Xiaoping Wang